Nuage Therapeutics
PrivateLast Round
Grant
Dec 2, 2025
Total Funding Raised
$18.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nuage Therapeutics is a biotechnology company that develops drugs designed to target intrinsically disordered proteins for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuage Therapeutics Comparables
Compare Nuage Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kodiform Therapeutics | 87% | |
| Nereid | 86% | |
| Transition Bio, Inc. | 85% | |
Nuage Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2025 | ||||
| Seed | May 26, 2025 | ||||
| Seed | Jun 20, 2023 |
Key People
Founding team and executive leadership
Nuage Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Seed |
| Agencia Estatal de Investigación | Grant |
| Sofinnova Partners | Seed |
| Center for Technological Development and Innovation | Seed |
| BStartup Banco Sabadell | Seed |
| Innvierte | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 98% MoM, reaching 1.1K.
- Dec 2, 2025
$3.1M grant received from Agencia Estatal de Investigación.
Nuage Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuage Therapeutics's valuation, stock price, and market status.